Israel conflict unlikely to impact trade of pharma firms

Indian pharmaceutical firms foresee minimal disruptions in trade with Israel despite escalating regional tensions. Photograph: Yves Herman/Reuters Rising crude prices and export shipping insurance......

Sun Pharma's growth prospects look healthy; analysts positive on the stock

Sun Pharmaceutical Industries (Sun Pharma) reported a turnaround in the January-March quarter of the 2022-23 financial year (Q4FY23), declaring a profit after tax (PAT) of Rs 1,984 crore versus a......

Will Sudhir Valia, Suraksha's 'deal maker' manage to bag Jaypee Infra?

Suraksha started by funding developers for projects, and then evolved into realty angel investing. Dev Chatterjee reports. IMAGE: Suraksha Smart City - Vasai-Virar's biggest township under......

Markets reel under shell firm order, Sensex at 3-week low

Healthcare, auto and financial stocks lagged. Illustration: Uttam Ghosh/Rediff.com It was the third straight session of loss for stocks on Wednesday as the Sensex took a hit of 216 points to close......